<DOC>
	<DOCNO>NCT02614885</DOCNO>
	<brief_summary>This single-arm , prospective study radiofrequency ablation device excise breast tissue ten ( 10 ) prophylactic mastectomy patient . The ablation lesion create device analyze histologically .</brief_summary>
	<brief_title>Feasibility Study Cavitary Radiofrequency Ablation Excised Mastectomy Breast Tissue</brief_title>
	<detailed_description>This study single-center , prospective , open label study radiofrequency ablation device . 10 patient schedule undergo prophylactic mastectomy recruit clinical investigator investigational site accordance inclusion exclusion criterion . Once breast tissue remove , radiofrequency ablation device use ex vivo tissue ablate lesion around cavity create tissue . The ablation lesion characterize . The study period per subject time take assess ablation lesion histologically .</detailed_description>
	<criteria>1 . Female 2 . At least 18 year age 3 . Scheduled receive standard care prophylactic mastectomy ( prophylactic bilateral mastectomy ) 4 . The patient ' breast ( ) include study undiseased 5 . The patient adequate breast volume ex vivo ablation procedure 1 . The patient receive skin spar mastectomy ( ) 2 . The patient previous exposure chemotherapy radiation therapy 3 . The patient implant breast ( ) include study 4 . The patient currently pregnant lactate 5 . The patient tissue marker implant breast include study ( unless remove create cavity ex vivo breast tissue ) 6 . The patient previous surgery breast ( ) include study ( unless study investigator determines affect validity data study ) 7 . The patient participate clinical study device drug may impact participant safety validity data acquire study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>